Adicet Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Adicet Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6M, a 19.5% increase year-over-year.
Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $22.2M, a 21.5% increase year-over-year.
Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.3M, a 18.3% increase from 2022.
Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.1M, a 36.9% increase from 2021.
Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.5M, a 138% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$22.2M	$6M	+$981K	+19.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$21.2M	$5.68M	+$914K	+19.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$20.3M	$4.91M	+$661K	+15.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-19
Q3 2023	$19.6M	$5.56M	+$1.37M	+32.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$18.2M	$5.02M	+$688K	+15.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	$17.5M	$4.77M	+$415K	+9.54%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	$17.1M	$4.25M	-$30K	-0.7%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-19
Q3 2022	$17.2M	$4.19M	+$1.66M	+65.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$15.5M	$4.34M	+$1.68M	+63%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$13.8M	$4.35M	+$1.31M	+43%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$12.5M	$4.28M	+$2.63M	+160%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$9.88M	$2.53M	-$437K	-14.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$10.3M	$2.66M	+$2.31M	+658%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	$8.01M	$3.04M	+$2.74M	+918%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$5.26M	$1.65M			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-15
Q3 2020		$2.97M	+$2.58M	+659%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$351K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$299K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q3 2019		$391K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.